These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

734 related items for PubMed ID: 16715128

  • 21. Regulation of the phosphorylation and integrity of protein synthesis initiation factor eIF4GI and the translational repressor 4E-BP1 by p53.
    Constantinou C, Clemens MJ.
    Oncogene; 2005 Jul 14; 24(30):4839-50. PubMed ID: 15897901
    [Abstract] [Full Text] [Related]

  • 22. Raptor-rictor axis in TGFbeta-induced protein synthesis.
    Das F, Ghosh-Choudhury N, Mahimainathan L, Venkatesan B, Feliers D, Riley DJ, Kasinath BS, Choudhury GG.
    Cell Signal; 2008 Feb 14; 20(2):409-23. PubMed ID: 18068336
    [Abstract] [Full Text] [Related]

  • 23. Phosphorylation dynamics of eukaryotic initiation factor 4E binding protein 1 (4E-BP1) is discordant with its potential to interact with eukaryotic initiation factor 4E (eIF4E).
    Showkat M, Beigh MA, Bhat BB, Batool A, Andrabi KI.
    Cell Signal; 2014 Oct 14; 26(10):2117-21. PubMed ID: 24975846
    [Abstract] [Full Text] [Related]

  • 24. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation.
    Follo MY, Mongiorgi S, Bosi C, Cappellini A, Finelli C, Chiarini F, Papa V, Libra M, Martinelli G, Cocco L, Martelli AM.
    Cancer Res; 2007 May 01; 67(9):4287-94. PubMed ID: 17483341
    [Abstract] [Full Text] [Related]

  • 25. Skeletal myocyte hypertrophy requires mTOR kinase activity and S6K1.
    Park IH, Erbay E, Nuzzi P, Chen J.
    Exp Cell Res; 2005 Sep 10; 309(1):211-9. PubMed ID: 15963500
    [Abstract] [Full Text] [Related]

  • 26. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck.
    Amornphimoltham P, Patel V, Sodhi A, Nikitakis NG, Sauk JJ, Sausville EA, Molinolo AA, Gutkind JS.
    Cancer Res; 2005 Nov 01; 65(21):9953-61. PubMed ID: 16267020
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Regulation of cap-dependent translation by insulin-like growth factor-1 in neuronal cells.
    Quevedo C, Salinas M, Alcázar A.
    Biochem Biophys Res Commun; 2002 Mar 01; 291(3):560-6. PubMed ID: 11855825
    [Abstract] [Full Text] [Related]

  • 29. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins.
    Wang X, Beugnet A, Murakami M, Yamanaka S, Proud CG.
    Mol Cell Biol; 2005 Apr 01; 25(7):2558-72. PubMed ID: 15767663
    [Abstract] [Full Text] [Related]

  • 30. Leucine stimulates HGF production by hepatic stellate cells through mTOR pathway.
    Tomiya T, Nishikawa T, Inoue Y, Ohtomo N, Ikeda H, Tejima K, Watanabe N, Tanoue Y, Omata M, Fujiwara K.
    Biochem Biophys Res Commun; 2007 Jun 22; 358(1):176-80. PubMed ID: 17466941
    [Abstract] [Full Text] [Related]

  • 31. Both mTORC1 and mTORC2 are involved in the regulation of cell adhesion.
    Chen L, Xu B, Liu L, Liu C, Luo Y, Chen X, Barzegar M, Chung J, Huang S.
    Oncotarget; 2015 Mar 30; 6(9):7136-50. PubMed ID: 25762619
    [Abstract] [Full Text] [Related]

  • 32. Clofibrate treatment promotes branched-chain amino acid catabolism and decreases the phosphorylation state of mTOR, eIF4E-BP1, and S6K1 in rat liver.
    Ishiguro H, Katano Y, Nakano I, Ishigami M, Hayashi K, Honda T, Goto H, Bajotto G, Maeda K, Shimomura Y.
    Life Sci; 2006 Jul 17; 79(8):737-43. PubMed ID: 16616211
    [Abstract] [Full Text] [Related]

  • 33. Eukaryotic Initiation Factor 4E (eIF4E) sequestration mediates 4E-BP1 response to rapamycin.
    Batool A, Majeed ST, Aashaq S, Majeed R, Shah G, Nazir N, Andrabi KI.
    Int J Biol Macromol; 2019 Mar 15; 125():651-659. PubMed ID: 30552925
    [Abstract] [Full Text] [Related]

  • 34. Meal feeding enhances formation of eIF4F in skeletal muscle: role of increased eIF4E availability and eIF4G phosphorylation.
    Vary TC, Lynch CJ.
    Am J Physiol Endocrinol Metab; 2006 Apr 15; 290(4):E631-42. PubMed ID: 16263769
    [Abstract] [Full Text] [Related]

  • 35. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E.
    Fingar DC, Richardson CJ, Tee AR, Cheatham L, Tsou C, Blenis J.
    Mol Cell Biol; 2004 Jan 15; 24(1):200-16. PubMed ID: 14673156
    [Abstract] [Full Text] [Related]

  • 36. Rheb activation of mTOR and S6K1 signaling.
    Hanrahan J, Blenis J.
    Methods Enzymol; 2006 Jan 15; 407():542-55. PubMed ID: 16757352
    [Abstract] [Full Text] [Related]

  • 37. Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53.
    Mungamuri SK, Yang X, Thor AD, Somasundaram K.
    Cancer Res; 2006 May 01; 66(9):4715-24. PubMed ID: 16651424
    [Abstract] [Full Text] [Related]

  • 38. Regulation of translation factors eIF4GI and 4E-BP1 during recovery of protein synthesis from inhibition by p53.
    Constantinou C, Clemens MJ.
    Cell Death Differ; 2007 Mar 01; 14(3):576-85. PubMed ID: 16990847
    [Abstract] [Full Text] [Related]

  • 39. Dual inhibition by S6K1 and Elf4E is essential for controlling cellular growth and invasion in bladder cancer.
    Kyou Kwon J, Kim SJ, Hoon Kim J, Mee Lee K, Ho Chang I.
    Urol Oncol; 2014 Jan 01; 32(1):51.e27-35. PubMed ID: 24239466
    [Abstract] [Full Text] [Related]

  • 40. Increase in S6K1 phosphorylation in human skeletal muscle following resistance exercise occurs mainly in type II muscle fibers.
    Koopman R, Zorenc AH, Gransier RJ, Cameron-Smith D, van Loon LJ.
    Am J Physiol Endocrinol Metab; 2006 Jun 01; 290(6):E1245-52. PubMed ID: 16434552
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.